MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 57 filers reported holding MONTE ROSA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $681,000 | – | 30,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $11,204,439 | 7.40% |
| NEA Management Company, LLC | 7,692,298 | $58,538,388 | 3.29% |
| Cormorant Asset Management, LP | 2,893,717 | $22,021 | 1.47% |
| Alphabet Inc. | 1,464,015 | $11,141,154 | 0.65% |
| Avoro Capital Advisors LLC | 4,325,000 | $32,913,250 | 0.49% |
| Casdin Capital, LLC | 510,882 | $3,887,812 | 0.30% |
| RTW INVESTMENTS, LP | 1,214,572 | $9,242,893 | 0.19% |
| Virtus Investment Advisers, Inc. | 12,638 | $96,175 | 0.06% |
| Woodline Partners LP | 511,351 | $3,891,381 | 0.05% |
| CORNERCAP INVESTMENT COUNSEL INC | 28,192 | $214,541 | 0.04% |